What is GH's five-year median EV/Sales?

8.6x. Half of GH's weekly readings over the last five years were higher and half were lower. This page has 273 weekly readings, from Aug 2, 2021 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares GH only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Guardant Health Inc (GH) valuation history

Health Care

$169.08

Latest weekly close · Market cap $22.5B

Historically high

As of Oct 24, 2026

GH's EV/Sales of 19.4x is higher than 91% of its weekly readings over the last five years.

Weekly EV/Sales with its 5-year range

EV/Sales each weekMiddle half of the last 5 years5-year median 8.6×

5-year median: 8.6×
10-year median: 8.7×
5-year low to high: 3.1×–34.5×
Versus 5-year median: +126%

EV/Sales

91stpercentile

of its weekly readings over the last five years

Historically high

Growth, last 12 months vs the year before

Revenue: +43%accelerating
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading

EV/Sales at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

GH EV/Sales at each year-end
Year-end	EV/Sales	5-year percentile
Dec 29, 2025	14.7×	80
Dec 30, 2024	6.4×	39
Dec 25, 2023	5.9×	14
Dec 26, 2022	6.9×	1
Dec 27, 2021	28.5×	Too little history

Health Care peers on EV/Sales

Each percentile compares a stock with its own last five years.

Compare GH with peers

Health Care peers of GH on EV/Sales
Stock	EV/Sales	Versus its own history	5-year percentile
CHEChemed Corp	2.7×	Below its usual range	20
CICigna	0.4×	Below its usual range	18
CVSCVS Health	0.4×	Within its usual range	54
DGXQuest Diagnostics	2.8×	Historically high	99
DVADaVita	1.6×	Within its usual range	58

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on GH

No articles about GH yet. How valuation percentiles work

Loading peers and related research…

About this history

What is GH's current EV/Sales?: GH's EV/Sales of 19.4x is higher than 91% of its weekly readings over the last five years.
What is GH's five-year median EV/Sales?: 8.6x. Half of GH's weekly readings over the last five years were higher and half were lower. This page has 273 weekly readings, from Aug 2, 2021 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares GH only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.